Spain
['Efficacy of Lu 31-130 in Patients With Schizophrenia', 'Hong Kong', 'Spain', 'A Randomised, Double-blind, Parallel-group, Active-controlled, Flexible Dose Study Exploring the Efficacy and Safety of 12 Weeks Treatment With Lu 31-130 in Patients With Schizophrenia', 65, 'clinical trial']